. .. Rationnel,

, Hypothèses de la recherche et justification des choix méthodologiques

, Collaborations pour la réalisation de ce projet

.. .. Données,

A. De-l'étude and .. .. ,

, Résultats préliminaires (prévalence des infections à HPV et des frottis anormaux à l'inclusion) : article en cours de rédaction

, Discussion des résultats préliminaires (résultats à l'inclusion)

C. Perspectives, Risques de cancers chez les patients atteints de mucoviscidose-Données du SNDS et du registre français de la mucoviscidose

A. De-l'étude and .. .. ,

, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses, IARC Monogr Eval Carcinog Risks Hum, vol.90, pp.1-636, 2007.

H. P. Van-de-nieuwenhof, L. Van-kempen, and J. A. De-hullu, The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned, Cancer Epidemiol Biomarkers Prev, vol.18, pp.2061-2068, 2009.

C. Rousset-jablonski, Q. Reynaud, and R. Nove-josserand, High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosis, Eur J Obstet Gynecol Reprod Biol, vol.221, pp.40-45, 2018.

R. Aggarwal, V. Suri, and S. Awasthi, Prevalence and genotypes of HPV in female renal transplant recipients in North India, Int J Gynecol Pathol, vol.33, pp.537-579, 2014.

K. Meeuwis, M. M. Van-rossum, and P. Van-de-kerkhof, Skin cancer and (pre)malignancies of the female genital tract in renal transplant recipients, Transpl Int, vol.23, pp.191-200, 2010.

S. T. Park, M. J. Song, and J. S. Park, Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients, World J Surg Oncol, vol.9, p.72, 2011.

K. Meeuwis, W. Melchers, and H. Bouten, Anogenital malignancies in women after renal transplantation over 40 years in a single center, Transplantation, vol.93, pp.914-936, 2012.

J. Adami, H. Gäbel, and B. Lindelöf, Cancer risk following organ transplantation: a nationwide cohort study in Sweden, Br J Cancer, vol.89, pp.1221-1228, 2003.

H. S. Patel, A. R. Silver, and T. Levine, Human papillomavirus infection and anal dysplasia in renal transplant recipients, Br J Surg, vol.97, pp.1716-1737, 2010.

M. Arbyn, A. Bryant, P. Beutels, P. P. Martin-hirsch, E. Paraskevaidis et al., Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors, Cochrane Database Syst Rev, 2011.

E. Herweijer, K. Sundström, and A. Ploner, Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study, Int J Cancer, vol.138, pp.2867-74, 2016.

, Référentiel de pratiques pour la prévention et le dépistage du cancer du col de l'utérus, 2013.

. Haut-conseil-de-santé-publique, Vaccination des personnes immunodéprimées ou aspléniques. 2è éditions. Recommandations, 2014.

J. Haesebaert, D. Lutringer-magnin, and J. Kalecinski, French women's knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14 -18 year old daughters: a quantitative-qualitative study, BMC Public Health, vol.12, p.1034, 2012.

, International Standard Classification of Education ISCED 1997, reed, UNESCO, 2006.

J. Gaudelus, R. Cohen, and A. Martinot,

, Med Mal Infect, vol.44, pp.289-91, 2014.

A. Masson, O. Launay, and B. Delaisi, Vaccine coverage in CF children: A French multicenter study, J Cyst Fibros, vol.14, pp.615-635, 2015.

E. Pandolfi, E. Carloni, and M. G. Marino, Immunization coverage and timeliness of vaccination in Italian children with chronic diseases, Vaccine, vol.30, pp.5172-5180, 2012.

E. Petrosky, J. A. Bocchini, and S. Hariri, Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices, MMWR Morb Mortal Wkly Rep, vol.64, pp.300-304, 2015.

X. Martínez-gómez, A. Curran, and M. Campins, Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Euro Surveill, vol.24, 2016.

D. R. Nelson, A. M. Neu, and A. Abraham, Immunogenicity of Human Papillomavirus Recombinant Vaccine in Children with CKD, Clin J Am Soc Nephrol, vol.11, pp.776-84, 2016.

D. Kumar, E. R. Unger, and G. Panicker, Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients, Am J Transplant, vol.13, pp.2411-2418, 2013.

M. Drolet, É. Bénard, and M. Boily, Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis, Lancet Infect Dis, vol.15, pp.565-80, 2015.

C. Patel, J. M. Brotherton, and A. Pillsbury, The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?, Euro Surveill, vol.23, 2018.

A. R. Giuliano, E. A. Joura, and S. M. Garland, Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population

, Gynecol Oncol, vol.154, pp.110-117, 2019.

H. Lefevre, S. Samain, and N. Ibrahim, HPV vaccination and sexual health in France: Empowering girls to decide, Vaccine, vol.37, pp.1792-1800, 2019.

K. Trim, N. Nagji, L. Elit, and K. Roy, Parental Knowledge, Attitudes, and Behaviours towards Human Papillomavirus Vaccination for Their Children: A Systematic Review from, Obstet Gynecol Int, vol.2012, p.921236, 2001.

D. M. Holman, V. Benard, and K. B. Roland, Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature, JAMA Pediatr, vol.168, pp.76-82, 2014.

H. Lefèvre, C. Schrimpf, M. R. Moro, and J. Lachal, HPV vaccination rate in French adolescent girls: an example of vaccine distrust, Arch Dis Child, vol.103, pp.740-746, 2018.

D. Lutringer-magnin, C. Cropet, and G. Barone, HPV vaccination among French girls and women aged 14-23 years and the relationship with their mothers' uptake of Pap smear screening: a study in general practice, Vaccine, vol.31, pp.5243-5252, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02281852

J. Haesebaert, D. Lutringer-magnin, and J. Kalecinski, Disparities of perceptions and practices related to cervical cancer prevention and the acceptability of HPV vaccination according to educational level in a French cross-sectional survey of 18-65 years old women, PLoS ONE, vol.9, p.109320, 2014.

D. Lutringer-magnin, J. Kalecinski, G. Barone, and L. , Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing, Vaccine, vol.29, pp.5322-5330, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00698034

T. M. Kazmerski, G. S. Sawicki, and E. Miller, Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis, J Cyst Fibros, vol.17, pp.64-70, 2018.

, Vaincre la Mucoviscidose and Institut national d'études démographiques (Ined). French Cystic Fibrosis Registry, 2017.

D. H. Andersen, . Cystic, . Of, . Pancreas, . Its et al., A CLINICAL AND PATHOLOGIC STUDY. American Journal of Diseases of Children, vol.56, issue.2, 1938.

M. D. Parkins, V. M. Parkins, J. C. Rendall, and S. Elborn, Changing Epidemiology and Clinical Issues Arising in an Ageing Cystic Fibrosis Population, Ther Adv Respir Dis, vol.5, issue.2, pp.105-119, 2011.

G. Bellis, M. Cazes, A. Parant, M. Gaimard, C. Travers et al., Cystic Fibrosis Mortality Trends in France, J. Cyst. Fibros, vol.6, issue.3, pp.179-186, 2007.
URL : https://hal.archives-ouvertes.fr/halshs-00265504

P. Burgel, G. Bellis, H. V. Olesen, L. Viviani, A. Zolin et al., ERS/ECFS Task Force on Provision of Care for Adults with Cystic Fibrosis in Europe. Future Trends in Cystic Fibrosis Demography in 34 European Countries, Eur. Respir. J, vol.46, issue.1, pp.133-141, 2015.

R. Mahadeva, K. Webb, R. C. Westerbeek, N. R. Carroll, M. E. Dodd et al., Clinical Outcome in Relation to Care in Centres Specialising in Cystic Fibrosis: Cross Sectional Study, BMJ, issue.7147, pp.1771-1775, 1998.

P. M. Farrell, M. R. Kosorok, M. J. Rock, A. Laxova, L. Zeng et al., Early Diagnosis of Cystic Fibrosis through Neonatal Screening Prevents Severe Malnutrition and Improves Long-Term Growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group, Pediatrics, vol.107, issue.1, pp.1-13, 2001.

A. R. Smyth, S. C. Bell, S. Bojcin, M. Bryon, A. Duff et al., European Cystic Fibrosis Society Standards of Care: Best Practice Guidelines, J. Cyst. Fibros, vol.13, issue.1, pp.23-42, 2014.

, Relative à l'organisation Des Soins Pour La Prise En Charge Des Patients Atteints de Mucoviscidose

A. Diaz, J. Kang, S. P. Moore, P. Baade, D. Langbecker et al., Association between Comorbidity and Participation in Breast and Cervical Cancer Screening: A Systematic Review and Meta-Analysis, Cancer Epidemiol, vol.47, pp.7-19, 2017.

P. Constantinou, R. Dray-spira, and G. Menvielle, Cervical and Breast Cancer Screening Participation for Women with Chronic Conditions in France: Results from a National Health Survey, BMC Cancer, issue.1, p.16, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01297855

T. A. Pujol, N. Serban, J. Swann, and M. Kottke, Medicaid Claims for Contraception Among Women With Medical Conditions After Release of the US Medical Eligibility Criteria for Contraceptive Use, Prev Chronic Dis, vol.16, 2019.

A. E. Denoble, K. S. Hall, X. Xu, M. K. Zochowski, K. Piehl et al., Receipt of Prescription Contraception by Commercially Insured Women with Chronic Medical Conditions, Obstet Gynecol, vol.123, issue.6, pp.1213-1220, 2014.

E. B. Schwarz and S. Manzi, Risk of Unintended Pregnancy among Women with Systemic Lupus Erythematosus, Arthritis Rheum, vol.59, issue.6, pp.863-866, 2008.

P. V. Rasmussen, M. Magyari, J. Y. Moberg, M. Bøgelund, U. F. Jensen et al., Patient Awareness about Family Planning Represents a Major Knowledge Gap in Multiple Sclerosis, Mult Scler Relat, vol.24, pp.129-134, 2018.

J. Yazdany, L. Trupin, R. Kaiser, G. Schmajuk, J. Z. Gillis et al., Contraceptive Counseling and Use among Women with Systemic Lupus Erythematosus: A Gap in Health Care Quality? Arthritis Care Res (Hoboken), vol.63, pp.358-365, 2011.

M. Birru-talabi, M. E. Clowse, S. J. Blalock, L. Moreland, N. Siripong et al., Contraception Use Among Reproductive-Age Women With Rheumatic Diseases, Arthritis Care Res (Hoboken), vol.2019, issue.8, pp.1132-1140

A. Burgner and M. A. Hladunewich, Women's Reproductive Health for the Nephrologist, Am. J. Kidney Dis, vol.74, issue.5, pp.675-681, 2019.

M. Østensen, Sexual and Reproductive Health in Rheumatic Disease, Nat Rev Rheumatol, vol.2017, issue.8, pp.485-493

D. Alpízar-rodríguez, N. Pluchino, G. Canny, C. Gabay, and A. Finckh, The Role of Female Hormonal Factors in the Development of Rheumatoid Arthritis, Rheumatology (Oxford), vol.2017, issue.8, pp.1254-1263

C. G. Parks, . De-souza-espindola, A. Santos, M. Barbhaiya, and K. H. Costenbader, Understanding the Role of Environmental Factors in the Development of Systemic Lupus Erythematosus, Best Pract Res Clin Rheumatol, vol.2017, issue.3, pp.306-320

G. D. Mishra, D. Anderson, D. A. Schoenaker, H. Adami, N. E. Avis et al., InterLACE: A New International Collaboration for a Life Course Approach to Women's Reproductive Health and Chronic Disease Events, Maturitas, vol.74, issue.3, pp.235-240, 2013.

A. Meguerditchian, D. Dauphinee, N. Girard, T. Eguale, K. Riedel et al., Do Physician Communication Skills Influence Screening Mammography Utilization? BMC, Health Serv Res, vol.12, p.219, 2012.

L. F. Jensen, A. F. Pedersen, B. Andersen, M. Vestergaard, and P. Vedsted, Non-Participation in Breast Cancer Screening for Women with Chronic Diseases and Multimorbidity: A Population-Based Cohort Study, BMC Cancer, vol.15, 2015.

I. Makedonov, S. Gu, and L. F. Paszat, investigators of Ontario Cancer Screening Research Network. Organized Breast Screening Improves Reattendance Compared to Physician Referral: A Case Control Study, BMC Cancer, vol.15, p.315, 2015.

A. Lofters, S. Guilcher, R. H. Glazier, S. Jaglal, J. Voth et al., Screening for Cervical Cancer in Women with Disability and Multimorbidity: A Retrospective Cohort Study in Ontario, Canada, CMAJ Open, vol.2014, issue.4, pp.240-247

K. M. Curtis, N. K. Tepper, and P. A. Marchbanks, Medical Eligibility Criteria for Contraceptive Use, J Womens Health, issue.6, pp.825-828, 1920.

S. W. Champaloux, N. K. Tepper, K. M. Curtis, L. B. Zapata, M. K. Whiteman et al., Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population, Obstet Gynecol, vol.126, issue.6, pp.1151-1159, 2015.

S. T. Fleming, H. G. Pursley, B. Newman, D. Pavlov, and K. Chen, Comorbidity as a Predictor of Stage of Illness for Patients with Breast Cancer, Med Care, vol.43, issue.2, pp.132-140, 2005.

C. Bernard, C. Pekny, C. O. Omukagah, C. O. Bernard, I. Manji et al., Integration of Contraceptive Services into Anticoagulation Management Services Improves Access to Long-Acting Reversible Contraception, Contraception, vol.98, issue.6, pp.486-491, 2018.

M. T. Heflin, K. I. Pollak, M. N. Kuchibhatla, L. G. Branch, and E. Z. Oddone, The Impact of Health Status on Physicians' Intentions to Offer Cancer Screening to Older Women, J. Gerontol. A Biol. Sci. Med. Sci, issue.8, pp.844-850, 2006.

, Etat Des Lieux et Recommandations Pour Le Dépistage Du Cancer Du Col de l'utérus En France, 2010.

, Référentiel de Pratiques Pour La Prévention et Le Dépistage Du Cancer Du Col de l'utérus, 2013.

, Dépistage Du Cancer Du Col de l'utérus. Organisation et Mise En Place Du Programme de Dépistage Organisé, 2019.

, Conduite à Tenir Devant Une Patiente Ayant Un Frottis Cervico-Utérin Anormal. Actualisation. Recommandations Pour La Pratique Clinique, ANAES, 2002.

, Prévention Du Cancer Du Col de l'utérus. Recommandations Pour La Pratique Clinique, 2007.

, Conduite à Tenir Devant Une Femme Ayant Une Cytologie Cervico-Utérine Anormale, 2017.

, Evaluation de La Recherche Des Papillomavirus Humains (HPV) En Dépistage Primaire Des Lésions Précancéreuses et Cancéreuses Du Col de l'utérus et de La Place Du Double Immuno-Marquage P16/Ki67, Haute Autorité de Santé (HAS), 2019.

R. Jablonski, C. Reynaud, Q. Perceval, M. Nove-josserand, R. Durupt et al., Contraceptive Practices and Cervical Screening in Women with Cystic Fibrosis, Hum. Reprod, vol.30, issue.11, pp.2547-2551, 2015.

T. M. Kazmerski, S. Borrero, L. K. Tuchman, D. J. Weiner, J. M. Pilewski et al., Provider and Patient Attitudes Regarding Sexual Health in Young Women With Cystic Fibrosis, Pediatrics, issue.6, p.137, 2016.

T. M. Kazmerski, G. S. Sawicki, E. Miller, K. A. Jones, K. Z. Abebe et al., Sexual and Reproductive Health Care Utilization and Preferences Reported by Young Women with Cystic Fibrosis, J. Cyst. Fibros, vol.17, issue.1, pp.64-70, 2018.

M. T. Britto, J. M. Garrett, M. A. Dugliss, C. W. Daeschner, C. A. Johnson et al., Risky Behavior in Teens with Cystic Fibrosis or Sickle Cell Disease: A Multicenter Study, Pediatrics, vol.101, issue.2, pp.250-256, 1998.

A. Fair, K. Griffiths, and L. M. Osman, Attitudes to Fertility Issues among Adults with Cystic Fibrosis in Scotland. The Collaborative Group of Scottish Adult CF Centres, Thorax, vol.55, issue.8, pp.672-677, 2000.

T. M. Kazmerski, L. K. Tuchman, S. Borrero, D. Weiner, J. M. Pilewski et al., Cystic Fibrosis Program Directors' Attitudes toward Sexual and Reproductive Health in Young Women with CF, Pediatr. Pulmonol, vol.51, issue.1, pp.22-27, 2016.

K. B. Frayman and S. M. Sawyer, Sexual and Reproductive Health in Cystic Fibrosis: A Life-Course Perspective, Lancet Respir Med, vol.2015, issue.1, pp.70231-70231

T. Havermans, J. Abbott, K. Colpaert, and K. De-boeck, Communication of Information about Reproductive and Sexual Health in Cystic Fibrosis. Patients, Parents and Caregivers' Experience, J. Cyst. Fibros, vol.10, issue.4, pp.221-227, 2011.

K. B. Frayman, B. Cerritelli, J. Wilson, and S. M. Sawyer, Reproductive and Sexual Health in Boys with Cystic Fibrosis: What Do Parents Know and Say?, Pediatr. Pulmonol, vol.43, issue.11, pp.1107-1116, 2008.

T. M. Kazmerski, E. B. Nelson, L. R. Newman, M. J. Haviland, D. Luff et al., Interprofessional Provider Educational Needs and Preferences Regarding the Provision of Sexual and Reproductive Health Care in Cystic Fibrosis, J. Cyst. Fibros, vol.18, issue.5, pp.671-676, 2019.

T. M. Kazmerski, S. Borrero, G. S. Sawicki, K. Z. Abebe, K. A. Jones et al., Provider Attitudes and Practices toward Sexual and Reproductive Health Care for Young Women with Cystic Fibrosis, J Pediatr Adolesc Gynecol, vol.2017, issue.5, pp.546-552

P. Mittal, Use of a Modified Reproductive Life Plan to Improve Awareness of Preconception Health in Women with Chronic Disease, The Permanente Journal, vol.2014, issue.2, pp.28-32

J. Sotolongo, L. D. House, S. Swanson, and S. E. Davis, Integrated Community Strategies for Linking Youth to Adolescent Reproductive Health Services: A Case Study, J Adolesc Health, vol.2017, issue.3S, pp.45-50

A. Korzeniewska-eksterowicz, P. Majak, T. Grzelewski, and W. Stelmach, Stelmach, I. Impact of an SRH Education Programme on Cystic Fibrosis Patients in Poland, J Fam Plann Reprod Health Care, vol.39, issue.1, pp.60-61, 2013.

D. Charron-prochownik, S. M. Sereika, D. Becker, N. H. White, P. Schmitt et al., Long-Term Effects of the Booster-Enhanced READY-Girls Preconception Counseling Program on Intentions and Behaviors for Family Planning in Teens with Diabetes, Diabetes Care, vol.36, issue.12, pp.3870-3874, 2013.

D. Charron-prochownik, M. Ferons-hannan, S. Sereika, and D. Becker, Randomized Efficacy Trial of Early Preconception Counseling for Diabetic Teens (READY-Girls), Diabetes Care, vol.31, issue.7, pp.1327-1330, 2008.

R. P. Insinga, A. G. Glass, and B. B. Rush, Diagnoses and Outcomes in Cervical Cancer Screening: A Population-Based Study, American Journal of Obstetrics and Gynecology, vol.191, issue.1, pp.105-113, 2004.

F. F. Hamers, N. Duport, and N. Beltzer, Population-Based Organized Cervical Cancer Screening Pilot Program in France, European Journal of Cancer Prevention, vol.27, issue.5, pp.486-492, 2018.

C. Clavel, M. Masure, J. P. Bory, I. Putaud, C. Mangeonjean et al., Human Papillomavirus Testing in Primary Screening for the Detection of High-Grade Cervical Lesions: A Study of 7932 Women, Br. J. Cancer, vol.84, issue.12, pp.1616-1623, 2001.

J. Monsonego, L. Zerat, K. Syrjänen, J. Zerat, J. S. Smith et al., Prevalence of Type-Specific Human Papillomavirus Infection among Women in France: Implications for Screening, Vaccination, and a Future Generation of Multivalent HPV Vaccines, Vaccine, vol.2012, issue.35, pp.5215-5221

I. Baussano, S. Franceschi, A. Gillio-tos, F. Carozzi, M. Confortini et al., Difference in Overall and Age-Specific Prevalence of High-Risk Human Papillomavirus Infection in Italy: Evidence from NTCC Trial, BMC Infect. Dis, vol.13, 2013.

, on behalf of the ARTISTIC Study Group

A. Sargent, A. Bailey, M. Almonte, A. Turner, C. Thomson et al., Prevalence of Type-Specific HPV Infection by Age and Grade of Cervical Cytology: Data from the ARTISTIC Trial, British Journal of Cancer, vol.98, issue.10, pp.1704-1709, 2008.

K. A. Meeuwis, L. B. Hilbrands, J. Inthout, B. F. Slangen, I. M. Hendriks et al., Cervicovaginal HPV Infection in Female Renal Transplant Recipients: An Observational, Self-Sampling Based, Cohort Study, Am. J. Transplant, vol.15, issue.3, pp.723-733, 2015.

R. Aggarwal, V. Suri, S. Awasthi, J. Naru, R. Nijhawan et al., Prevalence and Genotypes of HPV in Female Renal Transplant Recipients in North India, Int. J. Gynecol. Pathol, vol.33, issue.5, pp.537-542, 2014.

V. Dalstein, D. Riethmuller, J. Prétet, K. Carval, J. Sautière et al., Persistence and Load of High-Risk HPV Are Predictors for Development of High-Grade Cervical Lesions: A Longitudinal French Cohort Study: HPV Persistence and Load for HGSIL Development, International Journal of Cancer, vol.106, issue.3, pp.396-403, 2003.

A. F. Rositch, J. Koshiol, M. G. Hudgens, H. Razzaghi, D. M. Backes et al., Patterns of Persistent Genital Human Papillomavirus Infection among Women Worldwide: A Literature Review and Meta-Analysis: Meta-Analysis of HPV Persistence, International Journal of Cancer, vol.133, issue.6, pp.1271-1285, 2013.

X. Carcopino, N. Bolger, M. Henry, J. Mancini, L. Boubli et al., Evaluation of Type-Specific HPV Persistence and High-Risk HPV Viral Load Quantitation in HPV Positive Women under 30 with Normal Cervical Cytology, J. Med. Virol, vol.83, issue.4, pp.637-643, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00614696

M. Schmitt, C. Depuydt, I. Benoy, J. Bogers, J. Antoine et al., Multiple Human Papillomavirus Infections with High Viral Loads Are Associated with Cervical Lesions but Do Not Differentiate Grades of Cervical Abnormalities, J. Clin. Microbiol, vol.51, issue.5, pp.1458-1464, 2013.

B. Detournay, D. Granados-canal, and A. El-hasnaouil,

, Gynecol Obstet Fertil, vol.37, issue.2, pp.125-130, 2009.

J. Casalegno, M. Benchaib, K. Le-bail-carval, E. Piaton, P. Mathevet et al., Human Papillomavirus Genotype Distribution among French Women with and without Cervical Abnormalities, Int J Gynaecol Obstet, vol.114, issue.2, pp.116-119, 2011.

C. Pannier-stockman, C. Segard, S. Bennamar, J. Gondry, J. Boulanger et al., Prevalence of HPV Genotypes Determined by PCR and DNA Sequencing in Cervical Specimens from French Women with or without Abnormalities, J. Clin. Virol, vol.42, issue.4, pp.353-360, 2008.

,. De-villiers, C. Fauquet, T. R. Broker, H. Bernard, and . Zur-hausen, Classification of Papillomaviruses. Virology, vol.324, pp.17-27, 2004.

, Human Papillomaviruses: This Publication Represents the Views and Expert Opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Which Met in Lyon, vol.90, pp.15-22, 2005.

D. Solomon, D. Davey, R. Kurman, A. Moriarty, D. O'connor et al., Bethesda System: Terminology for Reporting Results of Cervical Cytology, JAMA, vol.287, issue.16, pp.2114-2119, 2001.

V. Bouvard, R. Baan, K. Straif, Y. Grosse, B. Secretan et al., A Review of Human Carcinogens--Part B: Biological Agents, Lancet Oncol, vol.10, issue.4, pp.70096-70104, 2009.

C. Tanton, K. Soldan, S. Beddows, C. H. Mercer, J. Waller et al., High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey, Cancer Epidemiol. Biomarkers Prev, vol.24, issue.5, pp.842-853, 2015.

E. Mzarico, M. D. Gómez-roig, L. Guirado, N. Lorente, and E. Gonzalez-bosquet, Relationship between Smoking, HPV Infection, and Risk of Cervical Cancer, Eur. J. Gynaecol. Oncol, vol.36, issue.6, pp.677-680, 2015.

R. M. Feng, S. Y. Hu, F. H. Zhao, R. Zhang, X. Zhang et al., Role of Active and Passive Smoking in High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Grade 2 or Worse, J Gynecol Oncol, vol.28, issue.5, 2017.

S. K. Kjaer, A. J. Van-den-brule, J. E. Bock, P. A. Poll, G. Engholm et al., Determinants for Genital Human Papillomavirus (HPV) Infection in 1000 Randomly Chosen Young Danish Women with Normal Pap Smear: Are There Different Risk Profiles for Oncogenic and Nononcogenic HPV Types? Cancer Epidemiol, Biomarkers Prev, vol.6, issue.10, pp.799-805, 1997.

P. K. Chan, A. R. Chang, J. L. Cheung, D. P. Chan, L. Y. Xu et al., Determinants of Cervical Human Papillomavirus Infection: Differences between High-and Low-Oncogenic Risk Types, J. Infect. Dis, vol.185, issue.1, pp.28-35, 2002.

S. Vaccarella, C. Behavior, H. Use, and . Papillomavirus, Pooled Analysis of the IARC Human Papillomavirus Prevalence Surveys, Cancer Epidemiology Biomarkers & Prevention, vol.15, issue.2, pp.326-333, 2006.

J. M. Deacon, C. D. Evans, R. Yule, M. Desai, W. Binns et al., Sexual Behaviour and Smoking as Determinants of Cervical HPV Infection and of CIN3 among Those Infected: A Case-Control Study Nested within the Manchester Cohort, Br. J. Cancer, vol.83, issue.11, pp.1565-1572, 2000.

R. L. Winer, S. Lee, J. P. Hughes, D. E. Adam, N. B. Kiviat et al., Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students, Am. J. Epidemiol, vol.157, issue.3, pp.218-226, 2003.

N. Muñoz, F. Méndez, H. Posso, M. Molano, A. J. Van-den-brule et al., Instituto Nacional de Cancerologia HPV Study Group. Incidence, Duration, and Determinants of Cervical Human Papillomavirus Infection in a Cohort of Colombian Women with Normal Cytological Results, J. Infect. Dis, vol.190, issue.12, pp.2077-2087, 2004.

R. Herrero, P. E. Castle, M. Schiffman, M. C. Bratti, A. Hildesheim et al., Epidemiologic Profile of Type-Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa Rica, J. Infect. Dis, vol.191, issue.11, pp.1796-1807, 2005.

J. Green, A. Berrington-de-gonzalez, J. S. Smith, S. Franceschi, P. Appleby et al., Human Papillomavirus Infection and Use of Oral Contraceptives, Br. J. Cancer, vol.88, issue.11, pp.1713-1720, 2003.

L. E. Manhart and L. A. Koutsky, Do Condoms Prevent Genital HPV Infection, External Genital Warts, or Cervical Neoplasia? A Meta-Analysis, Sex Transm Dis, vol.29, issue.11, pp.725-735, 2002.

S. Vaccarella, R. Herrero, M. Dai, P. J. Snijders, C. J. Meijer et al., Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys, Cancer Epidemiol. Biomarkers Prev, vol.15, issue.11, pp.2148-2153, 2006.

N. Muñoz, S. Franceschi, C. Bosetti, V. Moreno, R. Herrero et al., Multicentric Cervical Cancer Study Group. Role of Parity and Human Papillomavirus in Cervical Cancer: The IARC Multicentric Case-Control Study, Lancet, vol.359, issue.9312, pp.8151-8156, 2002.

J. Casalegno, K. Le-bail-carval, D. Eibach, M. Valdeyron, G. Lamblin et al., High Risk HPV Contamination of Endocavity Vaginal Ultrasound Probes: An Underestimated Route of Nosocomial Infection, PLoS ONE, vol.2012, issue.10

P. Guan, R. Howell-jones, N. Li, L. Bruni, S. De-sanjosé et al., Human Papillomavirus Types in 115,789 HPV-Positive Women: A Meta-Analysis from Cervical Infection to Cancer, Int. J. Cancer, vol.2012, issue.10, pp.2349-2359

H. D. Strickler, J. M. Palefsky, K. V. Shah, K. Anastos, R. S. Klein et al., Human Papillomavirus Type 16 and Immune Status in Human Immunodeficiency Virus-Seropositive Women, J. Natl. Cancer Inst, vol.95, issue.14, pp.1062-1071, 2003.

E. F. Tizzano, M. M. Silver, D. Chitayat, J. C. Benichou, and M. Buchwald, Differential Cellular Expression of Cystic Fibrosis Transmembrane Regulator in Human Reproductive Tissues. Clues for the Infertility in Patients with Cystic Fibrosis, Am. J. Pathol, vol.144, issue.5, pp.906-914, 1994.

E. A. Oppenheimer, A. L. Case, J. R. Esterly, and R. M. Rothberg, Cervical Mucus in Cystic Fibrosis: A Possible Cause of Infertility, Am. J. Obstet. Gynecol, vol.108, issue.4, pp.673-674, 1970.

L. E. Kopito, H. J. Kosasky, and H. Shwachman, Water and Electrolytes in Cervical Mucus from Patients with Cystic Fibrosis, Fertil. Steril, vol.24, issue.7, pp.512-516, 1973.

C. C. Hayslip, E. Hao, and S. J. Usala, The Cystic Fibrosis Transmembrane Regulator Gene Is Expressed in the Human Endocervix throughout the Menstrual Cycle, Fertil. Steril, vol.67, issue.4, pp.636-640, 1997.

K. D. Schoyer, F. Gilbert, and Z. Rosenwaks, Infertility and Abnormal Cervical Mucus in Two Sisters Who Are Compound Heterozygotes for the Cystic Fibrosis (CF) DeltaF508 and R117H/7T Mutations, Fertil. Steril, vol.90, issue.4, pp.1201-1220, 2008.

T. Iwata, T. Fujii, K. Morii, M. Saito, J. Sugiyama et al., Cytokine Profile in Cervical Mucosa of Japanese Patients with Cervical Intraepithelial Neoplasia, Int. J. Clin. Oncol, vol.20, issue.1, pp.126-133, 2015.

K. K. Azar, M. Tani, H. Yasuda, A. Sakai, M. Inoue et al., Increased Secretion Patterns of Interleukin-10 and Tumor Necrosis Factor-Alpha in Cervical Squamous Intraepithelial Lesions, Hum. Pathol, vol.35, issue.11, pp.1376-1384, 2004.

, Système National Des Données de Santé (SNDS)

A. Gaudineau, V. Ehlinger, C. Vayssière, B. Jouret, C. Arnaud et al., Âge à la ménarche : résultats français de l'étude, Health Behaviour in School-aged Children

G. Obstétrique and &. Fertilité, , vol.38, pp.385-387, 2010.

M. Johannesson, C. Gottlieb, and L. Hjelte, Delayed Puberty in Girls with Cystic Fibrosis despite Good Clinical Status, Pediatrics, vol.99, issue.1, pp.29-34, 1997.

W. Um?awska, D. Sands, and A. Zieli?ska, Age of Menarche in Girls with Cystic Fibrosis, Folia Histochem. Cytobiol, vol.48, issue.2, pp.185-190, 2010.

M. Bournez, G. Bellis, and F. Huet, Growth during Puberty in Cystic Fibrosis: A Retrospective Evaluation of a French Cohort, Arch. Dis. Child, vol.2012, issue.8, pp.714-720

T. M. Kazmerski, G. S. Sawicki, E. Miller, K. A. Jones, K. Z. Abebe et al., Sexual and Reproductive Health Behaviors and Experiences Reported by Young Women with Cystic Fibrosis, J. Cyst. Fibros, vol.17, issue.1, pp.57-63, 2018.

R. Jin, The Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) Modulates the Timing of Puberty in Mice, Journal of Medical Genetics, vol.43, issue.6, pp.29-29, 2006.

A. Galli-tsinopoulou, T. Moudiou, A. Mamopoulos, and M. Karamouzis, Nousia-Arvanitakis, S. Multifollicular Ovaries in Female Adolescents with Cystic Fibrosis, Fertility and Sterility, vol.85, issue.5, pp.1484-1487, 2006.

C. Rousset-jablonski, Q. Reynaud, R. Nove-josserand, I. Ray-coquard, Y. Mekki et al., Study conducted in Lyon France. High Proportion of Abnormal Pap Smear Tests and Cervical Dysplasia in Women with Cystic Fibrosis, Eur. J. Obstet. Gynecol. Reprod. Biol, vol.221, pp.40-45, 2018.

G. M. Nixon, J. A. Glazner, J. M. Martin, and S. M. Sawyer, Urinary Incontinence in Female Adolescents with Cystic Fibrosis, Pediatrics, vol.110, issue.2, p.22, 2002.

R. J. Mcvean, A. Orr, A. K. Webb, A. Bradbury, L. Kay et al., Treatment of Urinary Incontinence in Cystic Fibrosis, J. Cyst. Fibros, vol.2, issue.4, pp.171-176, 2003.

S. M. Sawyer, G. Bowes, and P. D. Phelan, Vulvovaginal Candidiasis in Young Women with Cystic Fibrosis, BMJ, vol.308, issue.6944, p.1609, 1994.

A. K. Webb and E. Woolnough, Candida Albicans Infection in Adults with Cystic Fibrosis, J R Soc Med, vol.46, pp.13-16, 1999.

M. Arbyn, A. Bryant, P. Beutels, P. P. Martin-hirsch, E. Paraskevaidis et al., Prophylactic Vaccination against Human Papillomaviruses to Prevent Cervical Cancer and Its Precursors, Cochrane Database Syst Rev, issue.4, 2011.

, Calendrier Des Vaccinations et Recommandations Vaccinales, 2019.

E. Herweijer, K. Sundström, A. Ploner, I. Uhnoo, P. Sparén et al., Quadrivalent HPV Vaccine Effectiveness against High-Grade Cervical Lesions by Age at Vaccination: A Population-Based Study, Int. J. Cancer, vol.138, issue.12, pp.2867-2874, 2016.

P. L. Mccormack, . Quadrivalent-human, and . Papillomavirus, 18) Recombinant Vaccine (Gardasil®): A Review of Its Use in the Prevention of Premalignant Anogenital Lesions, Cervical and Anal Cancers, and Genital Warts, Drugs, vol.11, issue.6, pp.1253-1283, 2014.

S. M. Garland, S. K. Kjaer, N. Muñoz, S. L. Block, D. R. Brown et al., Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-World Experience, Clin. Infect. Dis, vol.63, issue.4, pp.519-527, 2016.

, Avis Relatif à La Place Du Vaccin GARDASIL 9® Dans La Stratégie Actuelle de Prévention Des Infections à Papillomavirus Humains, 2017.

E. Petrosky, J. A. Bocchini, S. Hariri, H. Chesson, C. R. Curtis et al., Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices, MMWR Morb. Mortal. Wkly. Rep, vol.64, issue.11, pp.300-304, 2015.

A. R. Giuliano, E. A. Joura, S. M. Garland, W. K. Huh, O. Iversen et al., Nine-Valent HPV Vaccine Efficacy against Related Diseases and Definitive Therapy: Comparison with Historic Placebo Population, Gynecol. Oncol, vol.154, issue.1, pp.110-117, 2019.

J. Gaudelus, R. Cohen, A. Martinot, J. Stahl, T. Lery et al.,

, Med Mal Infect, vol.44, issue.7, pp.289-291, 2014.

D. Kumar, E. R. Unger, G. Panicker, P. Medvedev, L. Wilson et al., Immunogenicity of Quadrivalent Human Papillomavirus Vaccine in Organ Transplant Recipients, Am. J. Transplant, vol.2013, issue.9, pp.2411-2417

J. Haesebaert, D. Lutringer-magnin, J. Kalecinski, G. Barone, A. Jacquard et al., Women's Knowledge of and Attitudes towards Cervical Cancer Prevention and the Acceptability of HPV Vaccination among Those with 14 -18 Year Old Daughters: A Quantitative-Qualitative Study, BMC Public Health, vol.12, p.1034, 2012.

J. Haesebaert, D. Lutringer-magnin, J. Kalecinski, G. Barone, A. Jacquard et al., Disparities of Perceptions and Practices Related to Cervical Cancer Prevention and the Acceptability of HPV Vaccination According to Educational Level in a French Cross-Sectional Survey of 18-65 Years Old Women, PLoS ONE, vol.2014, issue.10

D. Lutringer-magnin, J. Kalecinski, G. Barone, Y. Leocmach, V. Regnier et al., Human Papillomavirus (HPV) Vaccination: Perception and Practice among French General Practitioners in the Year since Licensing, Vaccine, vol.29, issue.32, pp.5322-5328, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00698034

D. Lutringer-magnin, C. Cropet, G. Barone, G. Canat, J. Kalecinski et al., HPV Vaccination among French Girls and Women Aged 14-23 Years and the Relationship with Their Mothers' Uptake of Pap Smear Screening: A Study in General Practice, Vaccine, issue.45, pp.5243-5249, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02281852

C. Rousset-jablonski, Q. Reynaud, R. Nove-josserand, S. Durupt, and I. Durieu, Suivi et prise en charge gynécologique chez les femmes atteintes de mucoviscidose, Revue des Maladies Respiratoires, vol.35, issue.6, pp.592-603, 2018.

. Centre-de-référence-mucoviscidose, Protocole National de Diagnostic et de Soins (PNDS) Mucoviscidose. Filière Muco CFTR, 2017.